Advanced Unresectable Gastric Adenocarcinoma

2 clinical trials · Condition

Record	Firm	Date
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States (NCT07554521)	BeOne Medicines	2026-04-30
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer (NCT06251973)	Memorial Sloan Kettering Cancer Center	2024-02-01

Every clearance here is in the API, with alerts when new ones post.